Hina Waheed Chaudhry
Corporate Officer/Principal at Icahn School of Medicine at Mount Sinai
Profile
Hina Waheed Chaudhry was the founder of VentriNova, Inc. which was founded in 2006 where she held the title of Chief Scientific Officer.
Currently, she is the Director of Cardiovascular Regenerative Medicine at Icahn School of Medicine at Mount Sinai.
Dr. Chaudhry has an undergraduate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
Hina Waheed Chaudhry active positions
| Companies | Position | Start |
|---|---|---|
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | - |
Former positions of Hina Waheed Chaudhry
| Companies | Position | End |
|---|---|---|
VentriNova, Inc.
 VentriNova, Inc. Pharmaceuticals: MajorHealth Technology VentriNova, Inc. develops gene therapy for the regeneration of heart tissue in patients with heart failure and after myocardial infarction. The company was founded by Hina Waheed Chaudhry in 2006 and is headquartered in New York, NY. | Founder | - |
Training of Hina Waheed Chaudhry
| Harvard Medical School | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
VentriNova, Inc.
VentriNova, Inc. Pharmaceuticals: MajorHealth Technology VentriNova, Inc. develops gene therapy for the regeneration of heart tissue in patients with heart failure and after myocardial infarction. The company was founded by Hina Waheed Chaudhry in 2006 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Hina Waheed Chaudhry
